HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wigle, E D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wigle, E D.
Topic Collections
Right arrow Myocardial disease
Right arrowRelevant Article
Heart 2001;86:709-714 ( December )

Education in Heart


CARDIOMYOPATHY

The diagnosis of hypertrophic cardiomyopathy

E Douglas Wigle

Toronto General Hospital, University Health Network and University of Toronto, Toronto, Ontario, Canada

Correspondence to: E Douglas Wigle MD, Department of Medicine (Cardiology), Toronto General Hospital, 200 Elizabeth Street, 12-EN-217, Toronto, Ontario M5G 2C4, Canada

The first 150 words of the full text of this article appear below.

    Introduction

Although the pathology of hypertrophic cardiomyopathy (HCM) was first described by French pathologists in the mid 19th century, it remained for the virtually simultaneous reports of Brock and Teare in England some 43 years ago to bring modern attention to this fascinating entity.1 2 Subsequent to these surgical1 and pathological2 observations, there has been an almost exponential growth in the number of research reports and in our knowledge of HCM, and a number of extensive reviews have been published.3-9 HCM was initially thought to be relatively rare, but it is now recognised to be an important cause of morbidity and mortality in people of all ages. In tertiary referral populations the annual mortality is 3-4% per annum (higher in the young) and 1-2% per annum in non-referred populations. It occurs in 1 in 500 live births, making it as common as cystic fibrosis, and is the most common cause of sudden death during athletic . . . [Full text of this article]


Relevant Article

WEB TOP 10
Heart 2002 87: 280. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
M. W. Hansen and N. Merchant
MRI of Hypertrophic Cardiomyopathy: Part I, MRI Appearances
Am. J. Roentgenol., December 1, 2007; 189(6): 1335 - 1343.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991.
[Full Text] [PDF]


Home page
HeartHome page
A Woo, H Rakowski, J C Liew, M-S Zhao, C-C Liew, T G Parker, M Zeller, E D Wigle, and M J Sole
Mutations of the {beta} myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis
Heart, October 1, 2003; 89(10): 1179 - 1185.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. J. M. Kofflard, F. J. Ten Cate, C. van der Lee, and R. T. van Domburg
Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration
J. Am. Coll. Cardiol., March 19, 2003; 41(6): 987 - 993.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 BMJ Publishing Group Ltd & British Cardiovascular Society